搜索





搜索





Avidity Biosciences Inc

RNA

添加自选

12.900USD

-0.060-0.46%

交易中（美东）报价延迟15分钟

220.66M总市值

亏损市盈率 TTM

Avidity Biosciences Inc

12.900

-0.060-0.46%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

RNA 利润表

您可以在这里找到Avidity Biosciences Inc的年度或季度收入报告，以深入了解Avidity Biosciences Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

营业总收入

1148.25%19.64M

-71.11%859.00K

434.03%12.47M

88.12%3.85M

-55.60%1.57M

35.57%2.97M

-17.10%2.34M

-11.70%2.04M

58.67%3.54M

-20.80%2.19M

13.54%2.82M

6.34%2.32M

24.40%2.23M

49.51%2.77M

14.75%2.48M

-16.46%2.18M

-33.62%1.79M

-13.54%1.85M

23.88%2.16M

69.18%2.61M

99.12%2.70M

--2.14M

--1.75M

587.95%1.54M

--1.36M

--224.00K

--0.00

营业收入

1148.25%19.64M

-71.11%859.00K

434.03%12.47M

88.12%3.85M

-55.60%1.57M

35.57%2.97M

-17.10%2.34M

-11.70%2.04M

58.67%3.54M

-20.80%2.19M

13.54%2.82M

6.34%2.32M

24.40%2.23M

49.51%2.77M

14.75%2.48M

-16.46%2.18M

-33.62%1.79M

-13.54%1.85M

23.88%2.16M

69.18%2.61M

99.12%2.70M

--2.14M

--1.75M

587.95%1.54M

--1.36M

--224.00K

--0.00

营业费用

309.03%36.91M

-75.83%29.96M

100.34%201.28M

106.67%174.99M

64.86%133.09M

79.82%123.96M

63.52%100.47M

54.09%84.67M

34.93%80.73M

23.11%68.94M

29.60%61.44M

13.35%54.95M

65.02%59.83M

38.60%55.99M

50.78%47.41M

67.31%48.48M

36.50%36.26M

119.14%40.40M

137.99%31.44M

143.29%28.97M

253.77%26.56M

--18.43M

--13.21M

188.42%11.91M

245.35%7.51M

--4.13M

--2.17M

研发费用

140.12%16.66M

-85.06%14.29M

100.72%154.95M

116.02%138.13M

48.87%99.49M

81.05%95.63M

61.79%77.20M

49.84%63.94M

39.92%66.83M

15.80%52.82M

27.86%47.71M

7.25%42.67M

72.51%47.77M

38.35%45.61M

50.28%37.32M

75.24%39.79M

33.91%27.69M

142.07%32.97M

162.62%24.83M

152.74%22.71M

272.96%20.68M

--13.62M

--9.46M

254.68%8.98M

339.30%5.54M

--2.53M

--1.26M

折旧摊销及损耗

184.91%151.00K

-83.47%122.00K

48.73%1.06M

18.49%814.00K

22.46%785.00K

20.00%738.00K

18.33%710.00K

29.87%687.00K

60.25%641.00K

53.75%615.00K

50.00%600.00K

64.29%529.00K

27.39%400.00K

92.31%400.00K

100.00%400.00K

119.05%322.00K

190.74%314.00K

108.00%208.00K

98.02%200.00K

47.00%147.00K

8.00%108.00K

--100.00K

--101.00K

0.00%100.00K

7.53%100.00K

--100.00K

--93.00K

营业利润

-131.88%-17.28M

75.95%-29.10M

-92.40%-188.81M

-107.13%-171.14M

-70.39%-131.52M

-81.28%-120.99M

-67.39%-98.13M

-56.98%-82.63M

-34.01%-77.19M

-25.40%-66.74M

-30.48%-58.63M

-13.68%-52.63M

-67.14%-57.60M

-38.08%-53.23M

-53.45%-44.93M

-75.59%-46.30M

-44.44%-34.46M

-136.59%-38.55M

-155.36%-29.28M

-154.31%-26.37M

-287.92%-23.86M

---16.29M

---11.47M

-165.51%-10.37M

-182.89%-6.15M

---3.91M

---2.17M

净非营业利息收入（费用）

利息收入

----

-3.66%17.85M

-17.94%14.74M

21.16%14.48M

91.85%16.18M

189.34%18.53M

186.11%17.97M

107.05%11.95M

52.88%8.43M

131.06%6.41M

367.96%6.28M

844.52%5.77M

2106.40%5.52M

4940.00%2.77M

7794.12%1.34M

3718.75%611.00K

1462.50%250.00K

205.56%55.00K

-37.04%17.00K

-11.11%16.00K

-88.81%16.00K

--18.00K

--27.00K

--18.00K

--143.00K

--0.00

利息费用

----

--0.00

-100.00%0.00

--0.00

-89.22%131.00K

-79.03%78.00K

--1.22M

--372.00K

特殊收入（费用）

----

--0.00

100.00%0.00

----

--0.00

-1975.00%-75.00K

100.00%0.00

--4.00K

---3.00K

其他非经营性收入（费用）

21466.67%647.00K

-100.00%0.00

-63.79%-380.00K

-461.21%-651.00K

-330.69%-435.00K

291.43%201.00K

-1684.62%-232.00K

28.40%-116.00K

67.83%-101.00K

-483.33%-105.00K

-8.33%-13.00K

-8000.00%-162.00K

-1156.00%-314.00K

60.87%-18.00K

-9.09%-12.00K

0.00%-2.00K

-733.33%-25.00K

---46.00K

---11.00K

---2.00K

---3.00K

----

税前利润

-123.29%-16.63M

71.54%-29.10M

-116.97%-174.44M

-122.22%-157.31M

-68.14%-115.77M

-69.18%-102.26M

-53.55%-80.40M

-50.54%-70.79M

-31.42%-68.86M

-19.76%-60.44M

-20.09%-52.36M

-2.92%-47.02M

-53.04%-52.39M

-30.96%-50.47M

-48.93%-43.60M

-73.38%-45.69M

-43.58%-34.23M

-136.79%-38.54M

-155.91%-29.27M

-149.65%-26.35M

-291.85%-23.84M

---16.27M

---11.44M

-106.33%-10.56M

-138.72%-6.08M

---5.12M

---2.55M

所得税

----

--34.00K

----

--0.00

----

除税后利润

-123.29%-16.63M

71.51%-29.14M

-116.97%-174.44M

-122.22%-157.31M

-68.14%-115.77M

-69.18%-102.26M

-53.55%-80.40M

-50.54%-70.79M

-31.42%-68.86M

-19.76%-60.44M

-20.09%-52.36M

-2.92%-47.02M

-53.04%-52.39M

-30.96%-50.47M

-48.93%-43.60M

-73.38%-45.69M

-43.58%-34.23M

-136.79%-38.54M

-155.91%-29.27M

-149.65%-26.35M

-291.85%-23.84M

---16.27M

---11.44M

-106.33%-10.56M

-138.72%-6.08M

---5.12M

---2.55M

持续经营利润

-123.29%-16.63M

71.51%-29.14M

-116.97%-174.44M

-122.22%-157.31M

-68.14%-115.77M

-69.18%-102.26M

-53.55%-80.40M

-50.54%-70.79M

-31.42%-68.86M

-19.76%-60.44M

-20.09%-52.36M

-2.92%-47.02M

-53.04%-52.39M

-30.96%-50.47M

-48.93%-43.60M

-73.38%-45.69M

-43.58%-34.23M

-136.79%-38.54M

-155.91%-29.27M

-149.65%-26.35M

-291.85%-23.84M

---16.27M

---11.44M

-106.33%-10.56M

-138.72%-6.08M

---5.12M

---2.55M

归属于母公司的净利润

-123.29%-16.63M

71.51%-29.14M

-116.97%-174.44M

-122.22%-157.31M

-68.14%-115.77M

-69.18%-102.26M

-53.55%-80.40M

-50.54%-70.79M

-31.42%-68.86M

-19.76%-60.44M

-20.09%-52.36M

-2.92%-47.02M

-53.04%-52.39M

-30.96%-50.47M

-48.93%-43.60M

-73.38%-45.69M

-43.58%-34.23M

-136.79%-38.54M

-155.91%-29.27M

-149.65%-26.35M

-291.85%-23.84M

---16.27M

---11.44M

-106.33%-10.56M

-138.72%-6.08M

---5.12M

---2.55M

归属于普通股东的净利润

-123.29%-16.63M

71.51%-29.14M

-116.97%-174.44M

-122.22%-157.31M

-68.14%-115.77M

-69.18%-102.26M

-53.55%-80.40M

-50.54%-70.79M

-31.42%-68.86M

-19.76%-60.44M

-20.09%-52.36M

-2.92%-47.02M

-53.04%-52.39M

-30.96%-50.47M

-48.93%-43.60M

-73.38%-45.69M

-43.58%-34.23M

-136.79%-38.54M

-155.91%-29.27M

-149.65%-26.35M

-291.85%-23.84M

---16.27M

---11.44M

-106.33%-10.56M

-138.72%-6.08M

---5.12M

---2.55M

基本每股收益

-123.40%-0.97

-114.14%-1.70

-94.12%-1.27

-83.31%-1.21

-13.47%-0.90

-0.08%-0.80

7.78%-0.65

-0.51%-0.66

-6.13%-0.79

9.73%-0.79

13.99%-0.71

28.02%-0.66

-4.83%-0.74

-7.97%-0.88

-21.42%-0.82

-30.51%-0.92

-11.66%-0.71

-88.15%-0.82

-121.34%-0.68

-149.28%-0.70

-361.56%-0.64

---0.43

---0.31

-142.99%-0.28

-138.70%-0.14

---0.12

---0.06

稀释每股收益

-123.40%-0.97

-114.14%-1.70

-94.12%-1.27

-83.31%-1.21

-13.47%-0.90

-0.08%-0.80

7.78%-0.65

-0.51%-0.66

-6.13%-0.79

9.73%-0.79

13.99%-0.71

28.02%-0.66

-4.83%-0.74

-7.97%-0.88

-21.42%-0.82

-30.51%-0.92

-11.66%-0.71

-88.15%-0.82

-121.34%-0.68

-149.28%-0.70

-361.56%-0.64

---0.43

---0.31

-142.99%-0.28

-138.70%-0.14

---0.12

---0.06

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Avidity Biosciences Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 RNA 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Avidity Biosciences Inc 财年末的营收是多少？



Avidity Biosciences Inc 2025 财年营收为 18.62M，高于上一财年的10.90M。

Avidity Biosciences Inc 最近一个季度的营收是多少？



Avidity Biosciences Inc 最近一个季度的营收为 19.64M，同比增长 1148.25%。

Avidity Biosciences Inc 全年的净利润是多少？



Avidity Biosciences Inc 2025 财年净利润为 -49.50M。

Avidity Biosciences Inc 上一季度的净利润是多少？



Avidity Biosciences Inc 最近一个季度的净利润为 -16.63M。

Avidity Biosciences Inc 年度营业利润是多少？



Avidity Biosciences Inc 2025 财年的营业利润为 -49.63M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。